Urine Cytology Findings in Cases of Pseudocarcinomatous Urothelial Hyperplasia of the Bladder Often Represent a Diagnostic Challenge

Author:

Velez Torres Jaylou M.12,Lora-Gonzalez Manuel3,Duarte Ernesto Martinez4,Zein-Sabatto Bassel3,Aron Manju5,Gupta Nilesh S.6,Kerr Darcy A.78,Netto George J.3,Jorda Merce192,Kryvenko Oleksandr N.19102

Affiliation:

1. From the Department of Pathology and Laboratory Medicine (Velez Torres, Jorda, Kryvenko), University of Miami Miller School of Medicine, Miami, Florida

2. Sylvester Comprehensive Cancer Center (Velez Torres, Jorda, Kryvenko), University of Miami Miller School of Medicine, Miami, Florida

3. the Department of Pathology, The University of Alabama at Birmingham, Birmingham (Lora-Gonzalez, Zein-Sabatto, Netto)

4. the Department of Pathology, University of Florida, Gainesville (Martinez Duarte)

5. the Departments of Pathology and Urology, Keck School of Medicine, University of Southern California, Los Angeles (Aron)

6. the Department of Pathology, Henry Ford Health System, Detroit, Michigan (Gupta)

7. the Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire (Kerr)

8. The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire (Kerr)

9. Desai Sethi Urology Institute (Jorda, Kryvenko), University of Miami Miller School of Medicine, Miami, Florida

10. Department of Radiation Oncology (Kryvenko), University of Miami Miller School of Medicine, Miami, Florida

Abstract

Context.— Pseudocarcinomatous urothelial hyperplasia (PCUH) architecturally and cytologically mimics cancer. The urine cytology features of PCUH have not been described. Objective.— To describe PCUH features in urine cytology. Design.— We reviewed urine cytology cases with concurrent PCUH tissue specimens from 5 academic institutions and classified them by using The Paris System criteria. Results.— Thirty-nine patients included 31 men and 8 women with a mean age of 67 years (range, 39–87 years). All patients had prior pelvic irradiation, and most presented with hematuria (n = 27). The specimens included voided urine (n = 16); bladder washing (n = 11); and urine, not otherwise specified (n = 12). The specimen preparation included cytospin (n = 29) and ThinPrep (n = 10). Original interpretations were negative for high-grade urothelial carcinoma (n = 28), atypical urothelial cells (AUCs; n = 10), and high-grade urothelial carcinoma (HGUC; n = 1). Twenty-five urine specimens (64%) had findings of PCUH. These specimens were moderately cellular and composed of sheets, cohesive groups, or isolated urothelial cells. Nucleoli were present in 23 cases. The nuclear membrane was smooth to irregular (n = 9), smooth (n = 8), and irregular (n = 8). The chromatin was glassy (n = 8), vesicular (n = 7), hyperchromatic (n = 7), and vesicular to finely granular (n = 3). The cytoplasm varied from dense squamoid, to finely vacuolated, to vacuolated. Nucleomegaly was observed in all 25 specimens, and nuclear-cytoplasmic ratio greater than 0.5 was seen in 11 of 25 cases (44%). The background contained acute inflammation (n = 14), was clean (n = 9), and contained red blood cells (n = 2). All cases originally interpreted as AUCs and HGUC had PCUH features. Conclusions.— PCUH urine features can overlap with AUCs, HGUC, and other nonurothelial malignancies. In our cohort, 44% (11 of 25) of urine specimens with PCUH changes were initially misclassified. Recognition of cytologic features of PCUH is important to avoid overcalling reactive changes.

Publisher

Archives of Pathology and Laboratory Medicine

Subject

Medical Laboratory Technology,General Medicine,Pathology and Forensic Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3